Ophthalmic phenotype of TCIRG1 gene mutations in Chinese infantile malignant osteopetrosis

Wenhong Cao1,2, Wenbin Wei2, Qian Wu1

  • 1Department of Ophthalmology, Beijing Children's Hospital, National Center for Children's Health, National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.

BMJ Open Ophthalmology
|December 13, 2018
PubMed

Insights

Frameshift mutations in TCIRG1 cause more severe optic canal stenosis and optic atrophy in infantile malignant osteopetrosis patients. No differences in optic nerve conduction block were observed between mutation types.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatrics

Background:

  • Infantile malignant osteopetrosis (IMO) is a rare genetic disorder.
  • Mutations in the T-cell immune regulator 1 (TCIRG1) gene are a common cause of autosomal recessive osteopetrosis.
  • Ophthalmic complications are frequent in IMO, impacting vision and neurological function.

Purpose of the Study:

  • To investigate the specific ophthalmic phenotypes associated with TCIRG1 mutations in Chinese infants with IMO.
  • To compare the clinical features and severity of ocular manifestations between different types of TCIRG1 mutations (frameshift vs. point mutations).

Main Methods:

  • A cohort of 27 Chinese infants with TCIRG1-related osteopetrosis was studied.
  • Direct DNA sequencing was used to identify mutation types: 12 with frameshift (group F) and 15 with point mutations (group P).
  • Ophthalmic examinations included assessment of gaze quality, optic atrophy, optic canal stenosis, and Flash visual-evoked potential (FVEP).

Main Results:

  • Frameshift mutations were associated with earlier onset (1.8 months) compared to point mutations (4.3 months).
  • Severe ophthalmic phenotypes, including poor gaze quality (92% vs. 53%) and optic atrophy (67% vs. 20%), were significantly more prevalent in the frameshift group.
  • Optic canal stenosis was more pronounced in frameshift mutation cases (average diameter 1.45 mm vs. 1.87 mm).
  • FVEP showed abnormal waveforms in a higher proportion of eyes with frameshift mutations (42% vs. 17%).

Conclusions:

  • TCIRG1 frameshift mutations lead to more severe optic canal stenosis and optic atrophy in Chinese IMO patients.
  • Despite differences in structural damage, no significant difference in optic nerve conduction block was found between frameshift and point mutation groups.
Abstract

Related Concept Videos

Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.2K
Mutations01:39

Mutations

Overview
94.5K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
37.8K